Skip to main content

Marc Benathen

Equibles does not estimate personal net worth.

About Marc Benathen

Earlier roles on record: CFO at LifeMD, Inc. (LFMD) until March 31, 2026. LifeMD, Inc. reported in an 8-K filed March 18, 2026 that Marc Benathen resigned as Chief Financial Officer, effective March 31, 2026. The same filing states: “Mr. Benathen did not resign as a result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.” The proxy statement of LifeMD, Inc. reports total compensation of $2,600,566 for Marc Benathen in fiscal 2023, including a base salary of $425,000. Disclosed compensation is on record for 3 fiscal years. Marc Benathen has spoken on 19 earnings calls across 1 company, most recently for LifeMD, Inc. on March 9, 2026. The companies whose calls Marc Benathen spoke on are classified in the Healthcare sector.

“On March 16, 2026, LifeMD, Inc ("LifeMD" or the "Company") announced that its Chief Financial Officer Marc Benathen will be departing LifeMD to pursue a new opportunity.”
“Mr. Benathen did not resign as a result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.”
LifeMD, Inc. Form 8-K, filed March 18, 2026 · Read the filing

Marc Benathen on recent calls

“Our fourth quarter results were very strong and ahead of our previous guidance, driven by outperformance in all areas of the company. During the quarter, we added over 13,000 net new subscribers to our patient subscriber count.”
CFO, LifeMD, Inc. Q4 FY2025 Earnings Call ·
“Good afternoon, everyone, and thank you for your flexibility as we rescheduled this call from November 6 to today. Our third quarter telehealth business results were solid with year-over-year growth of 18% in revenue and 30% in adjusted EBITDA.”
CFO, LifeMD, Inc. Q3 FY2025 Earnings Call ·
“As Justin noted, our long-term financial outlook remains strong. Weight management, though experiencing some impact from higher refund rates from patients without coverage or for whom discounted cash pay pricing is still inaccessible, performed ahead of guidance plan in the second quarter.”
CFO, LifeMD, Inc. Q2 FY2025 Earnings Call ·
“LifeMD achieved very strong first quarter financial results, with total revenues increasing 49% versus the year-ago period to $65.7 million. Core Telehealth revenue grew by 70% versus the prior year, with standalone adjusted EBITDA of $5.3 million.”
CFO, LifeMD, Inc. Q1 FY2025 Earnings Call ·
“LifeMD achieved a very strong third quarter performance with total revenues growing 38% versus the year-ago period to $53.4 million. Core telehealth revenue grew by 65% versus the prior year with standalone adjusted EBITDA profitability at $2.5 million, which was up 200% sequentially versus the second quarter.”
CFO, LifeMD, Inc. Q3 FY2024 Earnings Call ·

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 LifeMD, Inc. (LFMD) $425,000 $2,600,566
2022 LifeMD, Inc. (LFMD) $378,750 $1,387,320
2021 LifeMD, Inc. (LFMD) $297,917 $4,855,790

Recent activity

Show 8 earlier activities